|
1
|
Montero PH and Patel SG: Cancer of the
oral cavity. Surg Oncol Clin N Am. 24:491–508. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dumache R, Rogobete AF, Andreescu N and
Puiu M: Genetic and epigenetic biomarkers of molecular alterations
in oral carcinogenesis. Clin Lab. 61:1373–1381. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Oji C and Chukwuneke F: Poor oral hygiene
may be the sole cause of oral cancer. J Maxillofac Oral Surg.
11:379–383. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
da Silva SD, Hier M, Mlynarek A, Kowalski
LP and Alaoui-Jamali MA: Recurrent oral cancer: Current and
emerging therapeutic approaches. Front Pharmacol. 3:1492012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kareemaghay S and Tavassoli M: Clinical
immunotherapeutic approaches for the treatment of head and neck
cancer. Int J Oral Maxillofac Surg. 48:419–436. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Carvalho ALKL, Kowalski LP, Agra IM,
Pontes E, Campos OD and Pellizzon AC: Treatment results on advanced
neck metastasis (N3) from head and neck squamous carcinoma.
Otolaryngol Head Neck Surg. 132:862–868. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ferris RL, Blumenschein G Jr, Fayette J,
Guigay J, Colevas AD, Licitra L, Harrington K, Kasper S, Vokes EE,
Even C, et al: Nivolumab for recurrent squamous-cell carcinoma of
the head and neck. N Engl J Med. 375:1856–1867. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cripps C, Winquist E, Devries MC,
Stys-Norman D and Gilbert R; Head Neck Cancer Disease Site Group, :
Epidermal growth factor receptor targeted therapy in stages III and
IV head and neck cancer. Curr Oncol. 17:37–48. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Daigo Y and Nakamura Y: From cancer
genomics to thoracic oncology: Discovery of new biomarkers and
therapeutic targets for lung and esophageal carcinoma. Gen Thorac
Cardiovasc Surg. 56:43–53. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Daigo Y, Takano A, Teramoto K, Chung S and
Nakamura Y: A systematic approach to the development of novel
therapeutics for lung cancer using genomic analyses. Clin Pharmacol
Ther. 94:218–223. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ishikawa N, Daigo Y, Takano A, Taniwaki M,
Kato T, Hayama S, Murakami H, Takeshima Y, Inai K, Nishimura H, et
al: Increases of amphiregulin and transforming growth factor-alpha
in serum as predictors of poor response to gefitinib among patients
with advanced non-small cell lung cancers. Cancer Res.
65:9176–9184. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ishikawa N, Daigo Y, Yasui W, Inai K,
Nishimura H, Tsuchiya E, Kohno N and Nakamura Y: ADAM8 as a novel
serological and histochemical marker for lung cancer. Clin Cancer
Res. 10:8363–8370. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kakiuchi S, Daigo Y, Ishikawa N, Furukawa
C, Tsunoda T, Yano S, Nakagawa K, Tsuruo T, Kohno N, Fukuoka M, et
al: Prediction of sensitivity of advanced non-small cell lung
cancers to gefitinib (Iressa, ZD1839). Hum Mol Genet. 13:3029–3043.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kato T, Daigo Y, Hayama S, Ishikawa N,
Yamabuki T, Ito T, Miyamoto M, Kondo S and Nakamura Y: A novel
human tRNA-dihydrouridine synthase involved in pulmonary
carcinogenesis. Cancer Res. 65:5638–5646. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kikuchi T, Daigo Y, Katagiri T, Tsunoda T,
Okada K, Kakiuchi S, Zembutsu H, Furukawa Y, Kawamura M, Kobayashi
K, et al: Expression profiles of non-small cell lung cancers on
cDNA microarrays: Identification of genes for prediction of
lymph-node metastasis and sensitivity to anti-cancer drugs.
Oncogene. 22:2192–2205. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Suzuki C, Daigo Y, Ishikawa N, Kato T,
Hayama S, Ito T, Tsuchiya E and Nakamura Y: ANLN plays a critical
role in human lung carcinogenesis through the activation of RHOA
and by involvement in the phosphoinositide 3-kinase/AKT pathway.
Cancer Res. 65:11314–11325. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kakiuchi S, Daigo Y, Tsunoda T, Yano S,
Sone S and Nakamura Y: Genome-wide analysis of organ-preferential
metastasis of human small cell lung cancer in mice. Mol Cancer Res.
1:485–499. 2003.PubMed/NCBI
|
|
19
|
Taniwaki M, Daigo Y, Ishikawa N, Takano A,
Tsunoda T, Yasui W, Inai K, Kohno N and Nakamura Y: Gene expression
profiles of small-cell lung cancers: Molecular signatures of lung
cancer. Int J Oncol. 29:567–575. 2006.PubMed/NCBI
|
|
20
|
Oshita H, Nishino R, Takano A, Fujitomo T,
Aragaki M, Kato T, Akiyama H, Tsuchiya E, Kohno N, Nakamura Y and
Daigo Y: RASEF is a novel diagnostic biomarker and a therapeutic
target for lung cancer. Mol Cancer Res. 11:937–951. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hayama S, Daigo Y, Yamabuki T, Hirata D,
Kato T, Miyamoto M, Ito T, Tsuchiya E, Kondo S and Nakamura Y:
Phosphorylation and activation of cell division cycle associated 8
by aurora kinase B plays a significant role in human lung
carcinogenesis. Cancer Res. 67:4113–4122. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ishikawa N, Daigo Y, Takano A, Taniwaki M,
Kato T, Tanaka S, Yasui W, Takeshima Y, Inai K, Nishimura H, et al:
Characterization of SEZ6L2 cell-surface protein as a novel
prognostic marker for lung cancer. Cancer Sci. 97:737–745. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kato T, Sato N, Hayama S, Yamabuki T, Ito
T, Miyamoto M, Kondo S, Nakamura Y and Daigo Y: Activation of
Holliday junction recognizing protein involved in the chromosomal
stability and immortality of cancer cells. Cancer Res.
67:8544–8553. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Suzuki C, Takahashi K, Hayama S, Ishikawa
N, Kato T, Ito T, Tsuchiya E, Nakamura Y and Daigo Y:
Identification of Myc-associated protein with JmjC domain as a
novel therapeutic target oncogene for lung cancer. Mol Cancer Ther.
6:542–551. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Takahashi K, Furukawa C, Takano A,
Ishikawa N, Kato T, Hayama S, Suzuki C, Yasui W, Inai K, Sone S, et
al: The neuromedin U-growth hormone secretagogue receptor
1b/neurotensin receptor 1 oncogenic signaling pathway as a
therapeutic target for lung cancer. Cancer Res. 66:9408–9419. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Taniwaki M, Takano A, Ishikawa N, Yasui W,
Inai K, Nishimura H, Tsuchiya E, Kohno N, Nakamura Y and Daigo Y:
Activation of KIF4A as a prognostic biomarker and therapeutic
target for lung cancer. Clin Cancer Res. 13:6624–6631. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yamabuki T, Takano A, Hayama S, Ishikawa
N, Kato T, Miyamoto M, Ito T, Ito H, Miyagi Y, Nakayama H, et al:
Dikkopf-1 as a novel serologic and prognostic biomarker for lung
and esophageal carcinomas. Cancer Res. 67:2517–2525. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fujitomo T, Daigo Y, Matsuda K, Ueda K and
Nakamura Y: Identification of a nuclear protein, LRRC42, involved
in lung carcinogenesis. Int J Oncol. 45:147–156. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Koinuma J, Akiyama H, Fujita M, Hosokawa
M, Tsuchiya E, Kondo S, Nakamura Y and Daigo Y: Characterization of
an Opa interacting protein 5 involved in lung and esophageal
carcinogenesis. Cancer Sci. 103:577–586. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nguyen MH, Koinuma J, Ueda K, Ito T,
Tsuchiya E, Nakamura Y and Daigo Y: Phosphorylation and activation
of cell division cycle associated 5 by mitogen-activated protein
kinase play a crucial role in human lung carcinogenesis. Cancer
Res. 70:5337–5347. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hayama S, Daigo Y, Kato T, Ishikawa N,
Yamabuki T, Miyamoto M, Ito T, Tsuchiya E, Kondo S and Nakamura Y:
Activation of CDCA1-KNTC2, members of centromere protein complex,
involved in pulmonary carcinogenesis. Cancer Res. 66:10339–10348.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Takano A, Ishikawa N, Nishino R, Masuda K,
Yasui W, Inai K, Nishimura H, Ito H, Nakayama H, Miyagi Y, et al:
Identification of nectin-4 oncoprotein as a diagnostic and
therapeutic target for lung cancer. Cancer Res. 69:6694–6703. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kobayashi Y, Takano A, Miyagi Y, Tsuchiya
E, Sonoda H, Shimizu T, Okabe H, Tani T, Fujiyama Y and Daigo Y:
Cell division cycle-associated protein 1 overexpression is
essential for the malignant potential of colorectal cancers. Int J
Oncol. 44:69–77. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Thang PM, Takano A, Yoshitake Y, Shinohara
M, Murakami Y and Daigo Y: Cell division cycle associated 1 as a
novel prognostic biomarker and therapeutic target for oral cancer.
Int J Oncol. 49:1385–1393. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Daigo K, Takano A, Thang PM, Yoshitake Y,
Shinohara M, Tohnai I, Murakami Y, Maegawa J and Daigo Y:
Characterization of KIF11 as a novel prognostic biomarker and
therapeutic target for oral cancer. Int J Oncol. 52:155–165.
2018.PubMed/NCBI
|
|
36
|
Nakamura M, Takano A, Thang PM, Tsevegjav
B, Zhu M, Yokose T, Yamashita T, Miyagi Y and Daigo Y:
Characterization of KIF20A as a prognostic biomarker and
therapeutic target for different subtypes of breast cancer. Int J
Oncol. 57:277–288. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Williams JM, Chen GC, Zhu L and Rest RF:
Using the yeast two-hybrid system to identify human epithelial cell
proteins that bind gonococcal Opa proteins: Intracellular gonococci
bind pyruvate kinase via their Opa proteins and require host
pyruvate for growth. Mol Microbiol. 27:171–186. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Stellfox ME, Nardi IK, Knippler CM and
Foltz DR: Differential binding partners of the Mis18α/β YIPPEE
domains regulate mis18 complex recruitment to centromeres. Cell
Rep. 15:2127–2135. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Nardi IK, Zasadzińska E, Stellfox ME,
Knippler CM and Foltz DR: Licensing of centromeric chromatin
assembly through the mis18α-mis18β heterotetramer. Mol Cell.
61:774–787. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fujita Y, Hayashi T, Kiyomitsu T, Toyoda
Y, Kokubu A, Obuse C and Yanagida M: Priming of centromere for
CENP-A recruitment by human hMis18alpha, hMis18beta, and M18BP1.
Dev Cell. 12:17–30. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang J, Liu X, Dou Z, Chen L, Jiang H, Fu
C, Fu G, Liu D, Zhang J, Zhu T, et al: Mitotic regulator Mis18β
interacts with and specifies the centromeric assembly of molecular
chaperone holliday junction recognition protein (HJURP). J Biol
Chem. 289:8326–8336. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
He X, Hou J, Ping J, Wen D and He J: Opa
interacting protein 5 acts as an oncogene in bladder cancer. J
Cancer Res Clin Oncol. 143:2221–2233. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Nakamura Y, Tanaka F, Nagahara H, Ieta K,
Haraguchi N, Mimori K, Sasaki A, Inoue H, Yanaga K and Mori M: Opa
interacting protein 5 (OIP5) is a novel cancer-testis specific gene
in gastric cancer. Ann Surg Oncol. 14:885–892. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
He J, Zhao Y, Zhao E, Wang X, Dong Z, Chen
Y, Yang L and Cui H: Cancer-testis specific gene OIP5: A downstream
gene of E2F1 that promotes tumorigenesis and metastasis in
glioblastoma by stabilizing E2F1 signaling. Neuro Oncol.
20:1173–1184. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCq method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chinn SB and Myers JN: Oral cavity
carcinoma: Current management, controversies, and future
directions. J Clin Oncol. 33:3269–3276. 2015. View Article : Google Scholar : PubMed/NCBI
|
